The number of new drugs approved in 2015 reached a 19-year high, the Associated Press reports. The US Food and Drug Administration approved 45 drugs with containing new ingredients last year, up from 2014's 41 new drugs. This, the AP adds, is the most since 1996.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

While gene therapies may have high price tags, they could be cheaper than the cost of managing disease, according to MIT's Technology Review.

Researchers are looking for markers that indicate which cancer patients may respond to immunotherapies, the Associated Press writes.

In Nature this week: paternal age associated with de novo mutations in children, and more.

Nature News writes that researchers are still wrangling over the role of the p-value.